All News
Year in Review: Multiple Myeloma
(MedPage Today) -- Advances in multiple myeloma treatment this year were marked by the resurrection of a drug that had been previously pulled off the market, new FDA approvals, and research suggestin
Read MoreFive Questions to Ask Your Doctor When Weighing a Hysterectomy
Many patients are confused about what their surgeons are planning. Here’s how to get the details.
Read MoreSo You’ve Had a Hysterectomy. Do You Know What Was Removed?
Patients often are in the dark about which organs remain and which were removed — particularly the ovaries, which profoundly influence lifelong health.
Read MoreDespite probe, China reimbursing AstraZeneca drug
The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite the country’s ongoing probes into maker AstraZeneca’s alleged illeg
Read MoreDoc Murdered 8 Patients? RFK Jr. Will 'Cost Lives'; $412M in Penile Injection Case
(MedPage Today) -- Note that some links may require registration or subscription.
Read MoreSTAT+: Pharmalittle: We’re reading about a former Trump FDA chief criticizing RFK Jr., a radiopharmaceuticals talent shortage, and more
Former FDA commissioner Scott Gottlieb is raising concerns with Senate Republicans about the president-elect’s selection of RFK Jr.
Read More¿Podrían los nuevos medicamentos para perder peso estar disponibles para todos?
Los medicamentos agonistas GLP-1, conocidos por los nombres comerciales Ozempic, Trulicity y Wegovy, han demostrado ser efectivos para la pérdida de peso y para el manejo de la diabetes tipo 2.
Read MoreStarmer says British state needs ‘complete rewiring’ as Chris Wormald appointed new cabinet secretary – UK politics live
Career civil servant will replace Simon Case as PM says government must be changed to deliver long-term reformNigel Farage, the Reform UK leader, has said that he does not believe a story saying Elon
Read MoreSTAT+: Novartis to pay $1 billion upfront to license Huntington’s drug from PTC
Novartis is paying $1 billion upfront in a licensing deal for an experimental Huntington’s disease treatment from PTC Therapeutics.
Read MoreBeatriz v El Salvador: the abortion case that could set a precedent across Latin America
Activists targeted as US-linked hard-right campaigns sow disinformation ahead of inter-American court of human rights ruling on case of woman who was denied abortion in 2013Earlier this year, Morena H
Read More